Pharmafile Logo
Pharmafocus logo
Advanced Search

biotech

Showing 15 posts of 861 posts found.

eye1

Novartis reveals more data for Eylea rival

May 1, 2018
Manufacturing and Production, Research and Development biotech, drugs, pharma, pharmaceutical

Building on the back of strong data released at the end of last year, Novartis has released further positive Phase …

News
gandhi

Lilly hires new leader of immuno-oncology

May 1, 2018
Manufacturing and Production, Medical Communications Eli Lilly, biotech, drugs, immunoconlogy, immunotherapy, pharma, pharmaceutical

Immuno-oncology has become a huge area of the oncology market, led by the wave of PD-1/L1 drugs that are reaping …

News
medopad

Connecting patients to doctors

April 30, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dan Vahdat, CEO and Co-founder of Medopad, discusses the rapid expansion of the app he helped develop, as its mobile …

Feature
piggy-2889042_960_720

Alzheon shies away from $81m IPO

April 30, 2018
Sales and Marketing Alzheon, biotech, drugs, pharma, pharmaceutical

Alzheon, a tiny biotech based in the Boston area, had initially launched its roadshow for an IPO potentially worth up …

News
canada_and_usa_flag

US applies pressure on Canada to stem cross-border generics flow

April 30, 2018
Sales and Marketing Canada, IP, US, biotech, drugs, pharma, pharmaceutical

The US has upped the ante against Canada to secure stronger border checks for pharmaceutical goods by adding the country …

News
becca

Health to hand

April 26, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Breast Cancer Care, biotech, drugs, pharma, pharmaceutical

Kristina Barrick is the Digital Innovation Manager at Breast Cancer Care and leads on the development of BECCA, the Breast …

Feature
houses-of-parliament-1055056_960_720

House of Lords unloads both barrels on Government’s life science strategy approach

April 26, 2018
Medical Communications ABPI, Life Sciences Industrial Strategy, UK government, biotech, drugs, pharma, pharmaceutical

The Life Sciences Industrial Strategy was supposed to forge a path forward for the industry, despite pressures from Brexit, to …

News

Takeda announce new UK MD, ahead of possible Shire transformation

April 26, 2018
Medical Communications Shire, Takeda, biotech, drugs, pharma, pharmaceutical

“Jon’s appointment comes at an exciting time for the company” reads the company press on annoucing its new Managing Director …

News
hands-981400_960_720

Common antidepressants linked to dementia risk

April 26, 2018
Medical Communications anticholinergic, biotech, dementia, drugs, pharma, pharmaceutical

A large study looking at the public’s use of anticholinergic drugs, such as those used to treat depression and Parkinson’s, …

News
phone_health

Novartis forges forward into digital pharma with FocalView app

April 25, 2018
Medical Communications, Research and Development FocalView, Novartis, biotech, drugs, pharma, pharmaceutical

There is a growing trend in big pharma to talk up the potential for digital technology to revolutionise operations and …

News
john_reed

Sanofi makes ex-Roche scientist new R&D chief

April 25, 2018
Medical Communications, Research and Development Roche, Sanofi, biotech, drugs, pharma, pharmaceutical

With the retirement of Elias Zerhouni as Head of Global R&D, Sanofi had to find a suitable replacement and believes …

News
china_block_001_takeda

$64bn Takeda-Shire mega merger inches closer to closing

April 25, 2018
Research and Development, Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical

From March onwards, Takeda has been nudging a deal with Shire onwards through repeatedly improved offers, which has seen the …

News

Lilly’s arthritis drug hits trouble at FDA committee

April 24, 2018
Manufacturing and Production, Sales and Marketing Eli Lilly, Incyte, biotech, drugs, pharma, pharmaceutical, rheumatoid arthritis

FDA’s advisory committee were openly conflicted about deciding on the safety of Eli Lilly and Incyte’s drug, baricitinib, for the …

News
astrazeneca_logo_building

AZ’s combo woes continue, with failure in lung cancer

April 24, 2018
Manufacturing and Production, Research and Development AstraZeneca, Imfinzi, biotech, drugs, pharma, pharmaceutical

AstraZeneca has been hit by a fresh blow in its search for an immunotherapy combination treatment that could differentiate it …

News
prothena-37882-2

Prothena collapses on double trial failure

April 23, 2018
Manufacturing and Production, Research and Development Prothena Therapeutics, biotech, drugs, pharma, pharmaceutical

Shares in Prothena have dropped by close to 70% on the news that two of its trials into its lead …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025